Viking Therapeutics Inc. – Filings and Transcripts

NASDAQ: VKTX
Share price (9/22/26): $40.85
Market cap (9/22/26): $4.765 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Automatic shelf registration

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Kelly-Gemmell Dorothy Elizabeth

Kelly-Gemmell Dorothy Elizabeth

Mancini Marianna

News Filter

Announces Positive Topline Results From Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC